Slow patent reform is blocking access to lifesaving medicines in South Africa, affecting public healthcare and affordability. Subscription Required You must be a subscriber to access all of this content. View Subscriptions Already a subscriber? Log in...
South Africa’s fight against AIDS and TB spotlights battles over high drug costs, patent monopolies, and the power of activism in securing affordable medicines for all. Subscription Required You must be a subscriber to access all of this content. View...
Following an agreement with the Competition Commission, J&J will not enforce its TB drug patent in 134 countries and will reduce the drug price in South Africa. Subscription Required You must be a subscriber to access all of this content. View Subscriptions...
